{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:02:01Z","timestamp":1791385321007,"version":"4.3.3"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,24]]},"abstract":"<jats:p>To investigate the clinical characteristics, early blood biochemical indicators, and prognostic status of children with bronchopneumonia. We conducted a retrospective analysis of data from 500 children diagnosed with bronchopneumonia at our hospital from June 2019 to December 2022. Based on the severity of the disease, patients were assigned to the severe group (n\u2005=\u2005180) or mild group (n\u2005=\u2005320), and an additional 150 healthy children were chosen as the control group. Blood indicators [aspartate aminotransferase (AST), plasma carbon dioxide combining power (CO2CP), serum potassium (K<jats:sup>+<\/jats:sup>), serum sodium (Na<jats:sup>+<\/jats:sup>)], inflammatory markers [interleukin-17 (IL-17), interleukin-10 (IL-10), C-reactive protein (CRP), procalcitonin (PCT)], and cardiac enzyme profiles [lactate dehydrogenase (LDH), creatine kinase (CK), alpha-hydroxybutyrate dehydrogenase (\u03b1-HBDH), creatine kinase isoenzyme (CK-MB)] were compared among the 3 groups. The severe group showed more signs such as diarrhea, pleural effusion, and respiratory distress than the mild group. AST levels in the severe group were significantly higher than those in the mild group and control group, while CO2CP, K<jats:sup>+<\/jats:sup>, and Na<jats:sup>+<\/jats:sup> were lower than those in the mild group and control group. AST levels in the mild group were significantly higher than those in the control group, while CO2CP and Na\u2005+\u2005were significantly higher than those in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). IL-10, IL-17, PCT, and CRP levels in the severe group were higher than those in the mild group and control group, while those in the mild group were higher than those in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). CK, CK-MB, LDH, and \u03b1-HBDH levels in the severe group were significantly higher than those in the mild group and control group. CK, CK-MB, LDH, and \u03b1-HBDH levels in the mild group were higher than those in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The severe group had a longer duration of fever, disappearance of symptoms, and cough relief time than the mild group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Children with bronchopneumonia exhibit increased cardiac enzyme (CK, CK-MB, LDH, and \u03b1-HBDH) activity, and PCT and CRP expression levels increase with disease severity. Timely detection of relevant blood biochemical indicators and early implementation of prevention and treatment measures can improve the cure rate and reduce mortality in children with bronchopneumonia.<\/jats:p>","DOI":"10.1097\/md.0000000000036162","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:03:36Z","timestamp":1701716616000},"page":"e36162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Clinical characteristics, early blood biochemical indicators, and prognostic status of children with bronchopneumonia"],"prefix":"10.1097","volume":"102","author":[{"given":"Yuanyuan","family":"Ling","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The First People\u2019s Hospital of Lin\u2019an District, Hangzhou City, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First People\u2019s Hospital of Lin\u2019an District, Hangzhou City, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3329-0416","authenticated-orcid":false,"given":"Sha","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First People\u2019s Hospital of Lin\u2019an District, Hangzhou City, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"1948519","DOI":"10.1155\/2019\/1948519","article-title":"Neonatal Streptococcus pneumoniae pneumonia induces an aberrant airway smooth muscle phenotype and AHR in mice model.","volume":"2019","author":"Peng","year":"2019","journal-title":"Biomed Res Int"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"17853","DOI":"10.1038\/s41598-019-54313-9","article-title":"Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia.","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"e062360","DOI":"10.1136\/bmjopen-2022-062360","article-title":"Novel care pathway to optimise antimicrobial prescribing for uncomplicated community-acquired pneumonia: study protocol for a prospective before\u2013after cohort study in the emergency department of a tertiary care Canadian children\u2019s hospital.","volume":"12","author":"Pernica","year":"2022","journal-title":"BMJ Open"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12890-021-01724-y","article-title":"LncRNA GAS5 participates in childhood pneumonia by inhibiting cell apoptosis and promoting SHIP-1 expression via downregulating miR-155.","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pulm Med"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"e00825","DOI":"10.1002\/prp2.825","article-title":"The therapeutic effects of naringenin on bronchial pneumonia in children.","volume":"9","author":"Yao","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/crj.13620","article-title":"Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.","volume":"17","author":"Fan","year":"2023","journal-title":"Clin Respir J"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/THC-192011","article-title":"Differences of TNF-\u03b1, IL-6 and Gal-3 in lobar pneumonia and bronchial pneumonia caused by mycoplasma pneumoniae.","volume":"28","author":"Tian","year":"2020","journal-title":"Technol Health Care"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jmii.2021.09.010","article-title":"The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019\u20132020.","volume":"55","author":"Kuo","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R10-20250524","first-page":"1304","article-title":"Expert consensus on diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children.","volume":"30","author":"Chen","year":"2015","journal-title":"Chin J Pract Pediatr"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06469-x","article-title":"Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children.","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-05830-4","article-title":"Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy.","volume":"21","author":"Zhu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.regg.2019.04.011","article-title":"Bilateral bronchopneumonia simulating cardiac decompensation easily detected with multi-window ultrasound.","volume":"55","author":"\u00c1lvarez-Troncoso","year":"2020","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"R14-20250524","first-page":"277","article-title":"Risk factors for concurrent lobar pneumonia in children with Mycoplasma pneumoniae pneumonia.","volume":"31","author":"Wang","year":"2021","journal-title":"Chin J Nosocomial Infect"},{"key":"R15-20250524","first-page":"998","article-title":"Diagnostic value of three cardiac enzyme markers in severe adenovirus pneumonia in children.","volume":"46","author":"Zhou","year":"2021","journal-title":"J Chongqing Med Univ"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1513\/AnnalsATS.201804-286OC","article-title":"Myocardial injury in critically ill patients with community-acquired pneumonia A cohort study.","volume":"16","author":"Frencken","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R17-20250524","first-page":"317","article-title":"Characteristics and risk factors analysis of Mycoplasma pneumoniae infection in children.","volume":"17","author":"Gao","year":"2022","journal-title":"Chin J Pathog Biol"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"17957","DOI":"10.1038\/s41598-019-54499-y","article-title":"The usefulness of lung ultrasound for the aetiological diagnosis of community-acquired pneumonia in children.","volume":"9","author":"Berce","year":"2019","journal-title":"Sci Rep"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/vms3.213","article-title":"Dermatophilus congolensis associated bronchopneumonia in an alpaca.","volume":"6","author":"Horadagoda","year":"2020","journal-title":"Vet Med Sci"},{"key":"R20-20250524","first-page":"94","article-title":"Clinical value of atomization therapy in children with bronchopneumonia.","volume":"74","author":"Han","year":"2022","journal-title":"Minerva Pediatr (Torino)"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"735093","DOI":"10.3389\/fped.2021.735093","article-title":"Analysis of clinical characteristics and risk factors of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia.","volume":"9","author":"Zhong","year":"2021","journal-title":"Front Pediatr"},{"key":"R22-20250524","first-page":"1199","article-title":"Correlation analysis between serum lncRNA MALAT1 and lncRNA GAS5 expression levels and disease severity and prognosis in children with Mycoplasma pneumoniae pneumonia.","volume":"17","author":"Tang","year":"2022","journal-title":"Chin J Pathog Biol"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fped.2019.00441","article-title":"Early diagnosis of mycoplasma pneumoniae in children: simultaneous amplification and testing (SAT) is the key.","volume":"7","author":"Li","year":"2019","journal-title":"Front Pediatr"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41598-021-81853-w","article-title":"The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children.","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"R25-20250524","first-page":"7","article-title":"Levels of serum IL-1R1, HMGB1, and inflammatory cytokines in children with Mycoplasma pneumoniae pneumonia and their clinical significance.","volume":"31","author":"Zou","year":"2021","journal-title":"Chin J Mod Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:01:12Z","timestamp":1748109672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":25,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036162","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}